Navigation Links
Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
Date:11/7/2011

treatment option for patients with metastatic melanoma in the liver, and were presented at the European Multidisciplinary Cancer Congress; Positive Phase 2 trial results from the neuroendocrine tumor cohort showing a 70% overall response rate were presented at the Cardiovascular and Interventional Radiological Society of Europe conference; announced encouraging top-line results for the hepatobiliary cohort and top-line results for metastatic colorectal cohort of the Phase 2 trial.
  • Leadership Team Expansion:  Addition of Graham G. Miao, M.S, MBA, Ph.D., as Executive Vice President, Chief Financial Officer; appointment of David McDonald, to newly created role of Executive Vice President, Business Development
  • Common Stock Offering: Successfully completed the sale of 5,000,000 shares of common stock in July 2011 for $23.6 million in net proceeds.

  • "Our company had a productive third quarter, with progress made in several areas toward commercialization of our CHEMOSAT system," said Eamonn P. Hobbs, President and CEO of Delcath. "While some of our goals have yet to be achieved, we are pleased that we will be able to meet emerging interest in CHEMOSAT with faster than expected development of our Generation Two version of the system, which we believe will not only improve filtration efficiency, but potentially lead to new therapeutic possibilities as well. Along with the positive clinical data released during the quarter, these and other developments have positioned us well to begin realizing the potential of the CHEMOSAT system in 2012."

    For the three months ended September 30, 2011, the Company's operating loss was $12.2 million, which included approximately $900,000 in non-cash stock-based compensation expense. This compares to an operating loss for the same period in the prior year of $7.4 million, which included approximately $1.4 million in non-cash stock-based compensation expense. General and administrative (G&
    '/>"/>

    SOURCE Delcath Systems, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
    2. FDA Schedules Delcath Pre-New Drug Application Meeting Date
    3. Delcath Announces Completion of Regulatory Notification Process in New Zealand
    4. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
    5. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
    6. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
    7. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
    8. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
    9. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
    10. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
    11. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... DALLAS , Jan. 15, 2014 /PRNewswire-iReach/ -- ... research report to its store . ... from aging of population, consumption upgrade and policy ... industry has seen rapid development over the years, ... yuan in 2006 to 9.85 billion yuan in ...
    (Date:1/15/2014)... AARP Foundation today announced it has established a ... the severe cold weather that has gripped much of ... helping those in need; so to support these emergency ... contributions up to $250,000, which could mean up to ... through AARP Foundation. (Logo: http://photos.prnewswire.com/prnh/20070209/NYF043LOGO ...
    (Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Office of Fair Trading (OFT) approval condition to the announced ... Incorporated (NASDAQ: VPHM).   As a result of ... approval, and Shire expects to complete the tender offer on ... to the satisfaction of all of the remaining conditions to ...
    Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
    (Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
    (Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
    (Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
    (Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
    (Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
    Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
    ... may put themselves at risk by talking on cell phones ... The researchers found that adults aged 59 to 81 took ... while talking on a mobile phone, and their heightened cautiousness ... adults on cell phones also were more likely to fail ...
    ... way to present risk statistics is key to helping ... found that health professionals and consumers may change their ... presented using alternative statistical formats. Risk statistics can ... lights. The different ways of expressing risk can prove ...
    ... , TUESDAY, March 15 (HealthDay News) -- Nearly 15 million ... of dementia, and the number is rising, according to a ... healthy may live as long as 20 or 25 years," ... the Alzheimer,s Association, which is publishing the report in the ...
    ... 2011 A UC Irvine infectious disease specialist will ... and Prevention research program to develop and test innovative ... Susan Huang medical director of epidemiology & infection ... Health Policy Research Institute affiliate and researchers from ...
    ... of a key biological receptor. The finding has the ... arthritis to respiratory disorders to wound healing, because it ... use in experimental drugs. The researchers are ... at The Scripps Research Institute and the University of ...
    ... experimental vaccine against the human norovirus the bug behind ... diarrhea and vomiting can generate a strong immune response ... Using a novel viral vector-based method to grow and ... designed to fight such infections as HIV and hepatitis C, ...
    Cached Medicine News:Health News:Poorly presented risk statistics could misinform health decisions 2Health News:Almost 15 Million Americans Now Caring for Loved One With Alzheimer's 2Health News:Almost 15 Million Americans Now Caring for Loved One With Alzheimer's 3Health News:UCI jointly receives CDC grant to combat health care-associated staph infections 2Health News:Finding of long-sought drug target structure may expedite drug discovery 2Health News:New vaccine candidate shows strong potential to prevent highly contagious norovirus 2Health News:New vaccine candidate shows strong potential to prevent highly contagious norovirus 3Health News:New vaccine candidate shows strong potential to prevent highly contagious norovirus 4
    ... onboard rail clamps mount ... tables and stretchers. The ... need for lifting. Easy ... stable surface combined with ...
    The DHS Basic Set is available with either self-tapping or non-self-tapping screws. Either instrument set provides complete instrumentation in one graphic case for use with the Universal Implant Set,...
    ... is a versatile, fully powered orthopaedic and ... traction facilities, a powered centre break and ... versatile too. ,<br.,In fact the RX600 is ... it is for traction procedures. The RX600 ...
    ... orthopedic trauma procedures. Part of the ... trauma table top provides a complete, ... positioning and provides for skin or ... hip pinnings; femur, supine or lateral ...
    Medicine Products: